Healthcare -
Biotechnology - NASDAQ - US
$ 1.36
0 %
$ 87.4 M
Market Cap
-0.88
P/E
INZY - TOTAL RECEIVABLES
Total Receivables INZY - Inozyme Pharma, Inc.
385 K
LAST VALUE
149.19%
2 YEAR CAGR
65.51%
5 YEAR CAGR
0.00%
10 YEAR CAGR